Role of Cholinergic System and Calcium Synchronization in Schizophrenia
April 2009
by Atmaram Yarlagadda, MD, and Anita H. Clayton, MD
Dr. Yarlagadda is from Newport News, Virginia, and Dr. Clayton is Professor, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia.
This is protected content.
Popularity: unranked [?]
Related posts
- Real-world Data on Atypical Antipsychotic Medication Side Effects
- Social Cognition: The Key Factor Predicting Social Outcome in People with Schizophrenia?
- A New Psychosocial Tool for Gaining Patient Understanding and Acceptance of Long-acting Injectable Antipsychotic Therapy
- Direct Measurement of Disability
- Prevention of Schizophrenia Relapse with Extended Release Quetiapine Fumarate Dosed Once Daily: A Randomized, Placebo-Controlled Trial in Clinically Stable Patients
- The 4-Item Negative Symptom Assessment (NSA-4) Instrument: A Simple Tool for Evaluating Negative Symptoms in Schizophrenia Following Brief Training
- The Genetics of Cognitive Impairment in Schizophrenia
- Current Management of Schizophrenia: Antipsychotic Monotherapy versus Combination Therapy
- COGNITION AND SCHIZOPHRENIA: Is There a Role for Cognitive Assessments in Diagnosis and Treatment?
Posted in Update on Blood Brain Barrier | No Comments »
